使用混合型闭环胰岛素泵评价成人1型糖尿病患者的严重和2级低血糖及相关危险因素

IF 6.3 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Micah Devore, Emily Hepworth, Annika Agni, Wen Ye, Stephanie A Amiel, Simon J Fisher, Yu Kuei Lin
{"title":"使用混合型闭环胰岛素泵评价成人1型糖尿病患者的严重和2级低血糖及相关危险因素","authors":"Micah Devore, Emily Hepworth, Annika Agni, Wen Ye, Stephanie A Amiel, Simon J Fisher, Yu Kuei Lin","doi":"10.1089/dia.2025.0126","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Despite advances in diabetes technologies, severe hypoglycemia (SH) and level 2 hypoglycemia (Lv2Hypo) persist among hybrid closed-loop (HCL) insulin pump users. This study assessed the relationship of impaired awareness of hypoglycemia (IAH) and other patient characteristics with SH and Lv2Hypo in HCL insulin pump users with type 1 diabetes. <b><i>Methods:</i></b> A cross-sectional survey assessed 6-month SH history, hemoglobin A1C, IAH (using the Hypoglycemia Awareness Questionnaire), and 30-day continuous glucose monitoring (CGM) data among adult HCL insulin pump users recruited from a national U.S. type 1 diabetes patient registry. Analyses included logistic regression, <i>t</i>-tests, and Chi-square tests. <b><i>Results:</i></b> Of 601 participants (female: 54%; mean age: 43), IAH and higher glucose coefficients of variation (CVs) were associated with both SH and spending ≥1% of time in Lv2Hypo (<i>P</i>s < 0.05). Individuals with SH were further characterized as having spent more time with glucose levels >180 mg/dL and >250 mg/dL and having a lower education level (<i>P</i>s < 0.05). CGM hypoglycemia measures were not associated with SH. Age and diabetes duration were not associated with experiencing SH or spending ≥1% of time in Lv2Hypo. Participants who both experienced SH and spent ≥1% of time in Lv2Hypo showed trends toward exhibiting the most severe IAH and the highest glucose CVs. <b><i>Conclusions:</i></b> Among adults with type 1 diabetes using HCL insulin pumps, IAH and higher glucose CVs are risk factors of experiencing SH and Lv2Hypo. Hyperglycemia and lower education level are also associated with a higher risk for experiencing SH.</p>","PeriodicalId":11159,"journal":{"name":"Diabetes technology & therapeutics","volume":" ","pages":""},"PeriodicalIF":6.3000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Characterizing Severe and Level 2 Hypoglycemia and Associated Risk Factors in Adults with Type 1 Diabetes Using Hybrid Closed-Loop Insulin Pumps.\",\"authors\":\"Micah Devore, Emily Hepworth, Annika Agni, Wen Ye, Stephanie A Amiel, Simon J Fisher, Yu Kuei Lin\",\"doi\":\"10.1089/dia.2025.0126\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background:</i></b> Despite advances in diabetes technologies, severe hypoglycemia (SH) and level 2 hypoglycemia (Lv2Hypo) persist among hybrid closed-loop (HCL) insulin pump users. This study assessed the relationship of impaired awareness of hypoglycemia (IAH) and other patient characteristics with SH and Lv2Hypo in HCL insulin pump users with type 1 diabetes. <b><i>Methods:</i></b> A cross-sectional survey assessed 6-month SH history, hemoglobin A1C, IAH (using the Hypoglycemia Awareness Questionnaire), and 30-day continuous glucose monitoring (CGM) data among adult HCL insulin pump users recruited from a national U.S. type 1 diabetes patient registry. Analyses included logistic regression, <i>t</i>-tests, and Chi-square tests. <b><i>Results:</i></b> Of 601 participants (female: 54%; mean age: 43), IAH and higher glucose coefficients of variation (CVs) were associated with both SH and spending ≥1% of time in Lv2Hypo (<i>P</i>s < 0.05). Individuals with SH were further characterized as having spent more time with glucose levels >180 mg/dL and >250 mg/dL and having a lower education level (<i>P</i>s < 0.05). CGM hypoglycemia measures were not associated with SH. Age and diabetes duration were not associated with experiencing SH or spending ≥1% of time in Lv2Hypo. Participants who both experienced SH and spent ≥1% of time in Lv2Hypo showed trends toward exhibiting the most severe IAH and the highest glucose CVs. <b><i>Conclusions:</i></b> Among adults with type 1 diabetes using HCL insulin pumps, IAH and higher glucose CVs are risk factors of experiencing SH and Lv2Hypo. Hyperglycemia and lower education level are also associated with a higher risk for experiencing SH.</p>\",\"PeriodicalId\":11159,\"journal\":{\"name\":\"Diabetes technology & therapeutics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":6.3000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes technology & therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/dia.2025.0126\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes technology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/dia.2025.0126","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

背景:尽管糖尿病技术取得了进步,但在混合型闭环(HCL)胰岛素泵使用者中,严重低血糖(SH)和2级低血糖(Lv2Hypo)仍然存在。本研究评估了1型糖尿病HCL胰岛素泵使用者的SH和Lv2Hypo与低血糖意识受损(IAH)和其他患者特征的关系。方法:一项横断面调查评估了从美国国家1型糖尿病患者登记处招募的成人HCL胰岛素泵使用者的6个月SH病史、血红蛋白A1C、IAH(使用低血糖意识问卷)和30天连续血糖监测(CGM)数据。分析包括逻辑回归、t检验和卡方检验。结果:601名参与者(女性54%;平均年龄:43岁)、IAH和较高的葡萄糖变异系数(CVs)与SH和Lv2Hypo时间≥1%相关(p < 0.05)。SH患者在血糖水平为>80 mg/dL和bbb250 mg/dL时的时间更长,且受教育程度较低(p < 0.05)。CGM低血糖测量与SH无关。年龄和糖尿病病程与经历SH或Lv2Hypo≥1%的时间无关。同时经历SH且Lv2Hypo时间≥1%的参与者表现出最严重IAH和最高葡萄糖CVs的趋势。结论:在使用HCL胰岛素泵的成人1型糖尿病患者中,IAH和较高的葡萄糖cv是发生SH和lv2hypoo的危险因素。高血糖和较低的教育水平也与经历SH的高风险相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Characterizing Severe and Level 2 Hypoglycemia and Associated Risk Factors in Adults with Type 1 Diabetes Using Hybrid Closed-Loop Insulin Pumps.

Background: Despite advances in diabetes technologies, severe hypoglycemia (SH) and level 2 hypoglycemia (Lv2Hypo) persist among hybrid closed-loop (HCL) insulin pump users. This study assessed the relationship of impaired awareness of hypoglycemia (IAH) and other patient characteristics with SH and Lv2Hypo in HCL insulin pump users with type 1 diabetes. Methods: A cross-sectional survey assessed 6-month SH history, hemoglobin A1C, IAH (using the Hypoglycemia Awareness Questionnaire), and 30-day continuous glucose monitoring (CGM) data among adult HCL insulin pump users recruited from a national U.S. type 1 diabetes patient registry. Analyses included logistic regression, t-tests, and Chi-square tests. Results: Of 601 participants (female: 54%; mean age: 43), IAH and higher glucose coefficients of variation (CVs) were associated with both SH and spending ≥1% of time in Lv2Hypo (Ps < 0.05). Individuals with SH were further characterized as having spent more time with glucose levels >180 mg/dL and >250 mg/dL and having a lower education level (Ps < 0.05). CGM hypoglycemia measures were not associated with SH. Age and diabetes duration were not associated with experiencing SH or spending ≥1% of time in Lv2Hypo. Participants who both experienced SH and spent ≥1% of time in Lv2Hypo showed trends toward exhibiting the most severe IAH and the highest glucose CVs. Conclusions: Among adults with type 1 diabetes using HCL insulin pumps, IAH and higher glucose CVs are risk factors of experiencing SH and Lv2Hypo. Hyperglycemia and lower education level are also associated with a higher risk for experiencing SH.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes technology & therapeutics
Diabetes technology & therapeutics 医学-内分泌学与代谢
CiteScore
10.60
自引率
14.80%
发文量
145
审稿时长
3-8 weeks
期刊介绍: Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信